Reminder: HPRA invites clinical experts to join expert panel - closing date 30 September 2022

News Category: Regulatory news

Date: 23/09/2022

The HPRA is inviting clinical experts to register their interest in contributing to the regulatory evaluation and assessment of medicines and medical devices through joining a new external expert panel. Collaborating with external clinical specialists, including doctors, pharmacists and other healthcare professionals, is an important part of how the HPRA continues to ensure public health is protected.

External experts may be requested to provide clinical input in relation to clinical studies and scientific advice for new products under development, applications to market innovative medicines that offer new treatment options for patients, and any emerging quality or safety concerns in relation to medicines and medical devices on the market.

Membership of the HPRA’s panel will provide clinical experts with an opportunity to develop a greater understanding of how health products are regulated nationally and in Europe, gain an insight into the development of innovative health products and contribute to ensuring that health products are safe and effective for patients. The HPRA both values the expertise of clinical specialists in Ireland and recognises the beneficial role their contribution adds to regulatory evaluation and assessment of health products.

The national regulator is seeking clinical expertise in the following areas:

  • Oncology and Haematology
  • Cardiovascular, Endocrinology, Renal, Respiratory
  • Gastroenterology, Rheumatology, Immunology, Dermatology
  • Neurology, Pain and Psychiatry
  • Infectious Diseases
  • Ophthalmology
  • Paediatrics and Geriatrics
  • Clinical Pharmacology
  • Diagnostic and Therapeutic Radiopharmaceuticals

Expressions of interest should be submitted via email to by 30 September 2022. Following an evaluation of the expressions of interest received, successful experts will be notified and their appointment will be confirmed following completion and review of a declaration of interest and confidentiality undertaking.

Further information, including details on how to apply, is available in the call for expressions of interest.

This news item was originally published on 22 August 2022.

« Back